Peptide-Based Antiviral Drugs.
Quick Facts
What This Study Found
60+ FDA-approved peptide drugs with 150+ in clinical trials. Antiviral peptides offer high specificity but face stability and delivery challenges addressable by chemical modification.
Key Numbers
60+ FDA approved; 150+ in clinical trials; since 1920; challenges: serum stability, oral BA, permeability; addressable by chemical modification
How They Did This
Book chapter reviewing antiviral peptide drugs, their mechanisms, advantages, disadvantages, and comparison with small molecules.
Why This Research Matters
New antiviral drugs are always needed. Peptides offer a different approach from traditional small molecules with potentially better specificity.
What This Study Doesn't Tell Us
Review/book chapter. Broad overview rather than deep analysis of specific antiviral peptides. Field is rapidly evolving.
Trust & Context
- Original Title:
- Peptide-Based Antiviral Drugs.
- Published In:
- Advances in experimental medicine and biology, 1322, 261-284 (2021)
- Database ID:
- RPEP-05631
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05631APA
Murugan, N Arul; Raja, K Muruga Poopathi; Saraswathi, N T. (2021). Peptide-Based Antiviral Drugs.. Advances in experimental medicine and biology, 1322, 261-284. https://doi.org/10.1007/978-981-16-0267-2_10
MLA
Murugan, N Arul, et al. "Peptide-Based Antiviral Drugs.." Advances in experimental medicine and biology, 2021. https://doi.org/10.1007/978-981-16-0267-2_10
RethinkPeptides
RethinkPeptides Research Database. "Peptide-Based Antiviral Drugs." RPEP-05631. Retrieved from https://rethinkpeptides.com/research/murugan-2021-peptidebased-antiviral-drugs
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.